Ke Lin
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Vaccine Coverage and Hesitancy
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 1
- Inflammatory Biomarkers in Disease Prognosis 1
- Viral-associated cancers and disorders 1
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Jingwen Ai (4 shared papers)Hongyu Wang (4 shared papers)Zhangfan Fu (4 shared papers)Yang Zhou (2 shared papers)Peng Cui (2 shared papers)Yuanhan Zhao (2 shared papers)H. C. Zhang (3 shared papers)Jieyu Song (2 shared papers)
- Journals
- Frontiers in Cellular and Infection Microbiology (2 papers)The Cerebellum (1 paper)Cancer Cell International (1 paper)Emerging Microbes & Infections (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ke Lin
9 papers receiving 98 citations
Peers
Comparison fields: 5 of 39
- Infectious Diseases 42
- Health 15
- Microbiology 1
- Emergency Medicine 13
- Clinical Biochemistry 9
Countries citing papers authored by Ke Lin
This map shows the geographic impact of Ke Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Lin more than expected).
Fields of papers citing papers by Ke Lin
This network shows the impact of papers produced by Ke Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Lin. The network helps show where Ke Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 29 | |
| 2 | 2022 | 25 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 9 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 6 | |
| 8 | 2022 | 2 | |
| 9 | 2025 | 2 | |
| 10 | 2025 | 0 | |
| 11 | 2024 | 0 |
About Ke Lin
Ke Lin is a scholar working on Oncology, Infectious Diseases, Surgery, Nephrology and Neurology, having authored 11 papers that have together received 98 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Cancer Treatment and Pharmacology (1 paper), Long-Term Effects of COVID-19 (1 paper), Inflammation biomarkers and pathways (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Viral-associated cancers and disorders (1 paper) and Parathyroid Disorders and Treatments (1 paper). The work is most often cited by research in Infectious Diseases (42 citations), Health (15 citations), Microbiology (1 citation), Emergency Medicine (13 citations) and Clinical Biochemistry (9 citations). Ke Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jingwen Ai, Hongyu Wang, Zhangfan Fu, Yang Zhou, Peng Cui, Yuanhan Zhao, H. C. Zhang, Jieyu Song, Wenhong Zhang and Honglong Wu. Their work appears in journals such as Frontiers in Cellular and Infection Microbiology, The Cerebellum, Cancer Cell International, Emerging Microbes & Infections and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.